This site is developed and hosted by bluebird bio (Switzerland) GmbH and is not intended for US and UK healthcare professionals.
This product has received European Medicines Agency approval. The registration status and approved product labels of ZYNTEGLO may vary from country to country. The information on this website is not country-specific and may not be applicable to your country. For more information, please refer to your local Prescribing Information.
IMPORTANT: The information on this website is based on the European Summary of Product Characteristics (EU SmPC)
This site is not intended for US and UK healthcare professionals. If you are a UK healthcare professional, please click here.
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.